Filing metadata

Accession number
0001209191-22-015606
Form type
Form 3
Filer
Janux Therapeutics, Inc.
CIK
CIK 1817713
Filed
Mar 03, 2022
Reporting period
Mar 01, 2022
Description
Initial ownership

Explore SEC Filings Hub